GNNSF
Price
$2.12
Change
-$0.17 (-7.42%)
Updated
Dec 2 closing price
Capitalization
3.75B
Intraday BUY SELL Signals
Interact to see
Advertisement

GNNSF

Header iconGNNSF Comparison
Open Charts GNNSFBanner chart's image
Genscript Biotech
Price$2.12
Change-$0.17 (-7.42%)
Volume$140
Capitalization3.75B
GNNSF Comparison Chart in %
GNNSF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.21B. The market cap for tickers in the group ranges from 58 to 113.14B. VRTX holds the highest valuation in this group at 113.14B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was 65%. NBY experienced the highest price growth at 158%, while BPTSY experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was 72%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 80
Price Growth Rating: 54
SMR Rating: 92
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (GNNSF: $2.12)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNNSF’s FA Score shows that 0 FA rating(s) are green while.

  • GNNSF’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNNSF’s TA Score shows that 1 TA indicator(s) are bullish.

  • GNNSF’s TA Score: 1 bullish, 7 bearish.

Price Growth

GNNSF (@Biotechnology) experienced а 0.00% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.68%. For the same industry, the average monthly price growth was +4.10%, and the average quarterly price growth was +64.61%.

Industries' Descriptions

@Biotechnology (+0.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNNSF
Capitalization3.75B
EBITDA-203.82M
Gain YTD66.929
P/E RatioN/A
Revenue1.01B
Total Cash1.87B
Total Debt448M
FUNDAMENTALS RATINGS
GNNSF: Fundamental Ratings
GNNSF
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
86
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
39
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GNNSF
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Advances
ODDS (%)
N/A
Declines
ODDS (%)
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bearish Trend 2 days ago
55%
View a ticker or compare two or three
Interact to see
Advertisement
GNNSF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWMIX59.680.65
+1.10%
Hotchkis & Wiley Mid-Cap Value I
LVOQX16.830.11
+0.66%
Lord Abbett Value Opportunities R2
FSMDX37.77N/A
N/A
Fidelity Mid Cap Index
FMDGX35.93N/A
N/A
Fidelity Mid Cap Growth Index
TIAGX14.92-0.39
-2.55%
Timothy Plan Small/Mid Cap Growth Cl I

GNNSF and Stocks

Correlation & Price change

A.I.dvisor tells us that GNNSF and ORYZF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNNSF and ORYZF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNNSF
1D Price
Change %
GNNSF100%
N/A
ORYZF - GNNSF
24%
Poorly correlated
N/A
ARGNF - GNNSF
23%
Poorly correlated
N/A
CLDI - GNNSF
23%
Poorly correlated
-2.00%
PRLD - GNNSF
20%
Poorly correlated
-1.21%
HNSBF - GNNSF
17%
Poorly correlated
N/A
More